NovaSterilis

10/27/2025

The delivers supercritical CO2 performance in a 60 lb., 24”x20”x12” package that is engineered for versatility and precision at lab scale to give researchers the control and repeatability they need. Learn more about this system: https://bit.ly/3Ow1SA6

10/24/2025

Dive into each stage of the process, from liquid fill to supercritical transition and return to ambient conditions. This is a look inside the pressure vessel- you can see the supercritical CO2 process—it will get you thinking of the possibilities..

Watch the process in full:

This short timelapse provides a complete perspective of the supercritical CO₂ sterilization process. Watch as the chamber:• Starts clear and empty• Fills wit...

10/23/2025

Allograft tendon sterilization SAL6, full cycle 240 minutes. sterilization is providing clinicians with sterile soft tissue. This study provides process and methods insight with results confirming SAL6 terminal sterility. Med Device and Tissue Banks can draw on this work for their manufacturing process development. Read more: https://bit.ly/3UxVdc3

10/22/2025

Balancing sterility assurance with material compatibility is a persistent challenge in manufacturing. Discover how sterilization can be an alternative to and traditional terminal methods:

As device complexity increases, supercritical CO₂ is redefining sterilization - going beyond the limits of aseptic manufacturing. Learn more.

10/21/2025

Selecting the right modality can directly influence data integrity and material performance in R&D environments. Learn how systems enable contamination control for temperature-sensitive materials and complex biomaterials: https://bit.ly/3Bk6t4l

10/20/2025

Achieving sterility assurance level 10-6 is a necessity for advanced and .

NovaSterilis’ approach offers deep pe*******on, short cycle times, and compatibility with sensitive materials. Explore how this terminal solution is helping innovators move from proof of concept to regulatory approval: https://bit.ly/42XHtrP

10/17/2025

As combination drug-delivery products become more complex, traditional methods can compromise material integrity and therapeutic function.

NovaSterilis’ process preserves both physical and biologic properties while enabling uniform bioactive deposition. Explore more: https://bit.ly/40fUNbI

10/16/2025

and are tightly connected as materials must allow effective sterilization while maintaining barrier integrity. For sensitive devices and biologics, requires compatible, gas-permeable packaging. Read our full blog to explore best practices and considerations: https://bit.ly/3zyKeXr

10/15/2025

This study dives into a novel method using and that showed promising results for preserving key growth factors in amniotic membrane allografts, which provides a powerful alternative to irradiation. Read the full study: https://bit.ly/41nAd9L

10/14/2025

Overkill, bioburden-based, and combined validation methods offer different balances of microbial reduction, material impact, and process complexity. For temperature-sensitive devices, supercritical carbon dioxide enables effective at mild conditions. Learn more:

Strong Bioburden control processes give device manufacturers more flexibility when choosing sterilization validation strategies. Read more.

10/13/2025

Discover the power of sterilization as a sustainable and effective method for processing , , and proteins in therapeutic drugs and medical devices. Download NovaSterilis' Therapeutic Sterilization Compatibility Guide today: https://bit.ly/45HI7ux

10/10/2025

Traditional methods present limitations for the tissue bank industry. offers a proven alternative that delivers terminal sterilization while preserving the native structure and function of allograft tissue.

Connect with our team to discuss how can advance your tissue sterilization process: https://bit.ly/3Cz9oU5